Skip to content

Goodwill at other companies

IAR
Integra LifeSciencesIART
$613.25M-44.5%
MiMedx Group logo
MiMedx GroupMDXG
$19.44M0.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$194.93M0.0%
Bioventus logo
BioventusBVS
$7.46M0.0%
Artivion logo
ArtivionAORT
$251.66M+2.7%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$65.95M0.0%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s goodwill?
Organogenesis Holdings Inc. (ORGO) reported goodwill of $28.77M in Q1 2026.
How has Organogenesis Holdings Inc.'s goodwill changed year-over-year?
Organogenesis Holdings Inc.'s goodwill decreased by 0.0% year-over-year, from $28.77M to $28.77M.
What is the long-term trend for Organogenesis Holdings Inc.'s goodwill?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $28.77M to $28.77M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.